Cardioprotective effect of ARB in old patients with hypertension and coronary artery disease - a multicenter trial -.

Cardioprotective effect of ARB in old patients with hypertension and coronary artery disease - a multicenter trial -. - Cardioprotection in the elderly by ARB

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000007273

Enrollment

100

Registered

2012-02-13

Start date

2012-02-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Elderly patients with hypertension and coronary artery disease

Interventions

Irbesartan Valsartan or Candesartan

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: History of coronary artery disease Over 60 years Hypertension and with at least one of risks of Diabetes mellitus Chronic kidney disease Obesity

Exclusion criteria

Exclusion criteria: Previous ARB-induced Hypersensitivity to ARB Serious impairment of liver function Serious renal dysfunction Hemodialysis treated Pregnant woman or who has possibility

Design outcomes

Primary

Measure	Time frame
Change in calcium score of coronary artery and aortic valve from baseline Change in echocardiography from baseline	—

Countries

Japan

Contacts

Public ContactSatoshi Nakatani

Osaka University Graduate School of medicine Division of Functional Diagnostics, Department of Health Sciences

06-6879-2561

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026